/ Addiction Content for �������ϲ����Ͽ� Davis en /news/new-compound-related-psychedelic-ibogaine-could-treat-addiction-depression <p>A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A paper describing the work is published Dec. 9 in Nature.</p> <p>“Psychedelics are some of the most powerful drugs we know of that affect the brain,” said David Olson, assistant professor of chemistry at �������ϲ����Ͽ� Davis and senior author on the paper. “It’s unbelievable how little we know about them.”</p> December 09, 2020 - 8:08am Andy Fell /news/new-compound-related-psychedelic-ibogaine-could-treat-addiction-depression